Mutations in the <i>SLC34A2</i> Gene are Associated with Pulmonary Alveolar Microlithiasis

Huqun(Saitama International Medical Center), Shinyu Izumi(Saitama International Medical Center), Hitoshi Miyazawa(Saitama International Medical Center), Kuniaki Ishii(Saitama International Medical Center), Bine Uchiyama(Saitama International Medical Center), Tadashi Ishida(Saitama International Medical Center), Sawako Tanaka(Saitama International Medical Center), Ryushi Tazawa(Saitama International Medical Center), Shunichiro Fukuyama(Saitama International Medical Center), Tomoaki Tanaka(Saitama International Medical Center), Yoshiaki Nagai(Saitama International Medical Center), Akemi Yokote(Saitama International Medical Center), Hiroki Takahashi(Saitama International Medical Center), Toshihiko Fukushima(Saitama International Medical Center), Kunihiko Kobayashi(Saitama International Medical Center), Hirofumi Chiba(Saitama International Medical Center), Makoto Nagata(Saitama International Medical Center), Susumu Sakamoto(Saitama International Medical Center), Koichiro Nakata(Saitama International Medical Center), Yuji Takebayashi(Saitama International Medical Center), Yoshihiko Shimizu(Saitama International Medical Center), Koichi Kaneko(Saitama International Medical Center), Michio SHIMIZU(Saitama International Medical Center), Minoru Kanazawa(Saitama International Medical Center), Shosaku Abe(Saitama International Medical Center), Yoshikazu Inoue(Saitama International Medical Center), Seiichi Takenoshita(Saitama International Medical Center), Kunihiko Yoshimura(Saitama International Medical Center), Koichiro Kudo(Saitama International Medical Center), T Tachibana(Saitama International Medical Center), Toshihiro Nukiwa(Saitama International Medical Center), Koichi Hagiwara(Saitama International Medical Center)
American Journal of Respiratory and Critical Care Medicine
November 9, 2006
Cited by 196

Abstract

RATIONALE: Pulmonary alveolar microlithiasis is an autosomal recessive disorder in which microliths are formed in the alveolar space. OBJECTIVES: To identify the responsible gene that causes pulmonary alveolar microlithiasis. METHODS: By means of a genomewide single-nucleotide polymorphism analysis using DNA from three patients, we have narrowed the region in which the candidate gene is located. From this region, we have identified a gene that has mutations in all patients with pulmonary alveolar microlithiasis. MEASUREMENTS AND MAIN RESULTS: We identified a candidate gene, SLC34A2, that encodes a type IIb sodium phosphate cotransporter and that is mutated in six of six patients investigated. SLC34A2 is specifically expressed in type II alveolar cells, and the mutations abolished the normal gene function. CONCLUSION: Mutations in the SLC34A2 gene that abolish normal gene function cause pulmonary alveolar microlithiasis.


Related Papers

No related papers found

Powered by citation graph analysis